-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On CervoMed with Overweight Rating

Benzinga·12/18/2025 13:02:49
Listen to the news
Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on CervoMed (NASDAQ:CRVO) with a Overweight rating.